Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Gossamer Bio, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 111 | 99 | −12 |
| Shares | 77.7M | 62.0M | −15.7M (−20.2%) |
| Value | $97.9M | $74.4M | −$23.5M (−24.0%) |
New holders (13)
Institutions that held Gossamer Bio, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Opaleye Management Inc. | 3,370,000 | $4.04M | 0.97% |
| Apis Capital Advisors, LLC | 180,000 | $216.0K | 0.22% |
| Verition Fund Management LLC | 170,000 | $204.0K | 0.00% |
| JustInvest LLC | 44,356 | $53.2K | 0.00% |
| Old Mission Capital LLC | 26,226 | $31.5K | 0.00% |
| Bayesian Capital Management, LP | 24,500 | $29.4K | 0.00% |
| Wolverine Trading, LLC | 24,297 | $29.4K | 0.00% |
| Silvercrest Asset Management Group LLC | 19,908 | $23.9K | 0.00% |
| Fisher Asset Management, LLC | 15,000 | $18.0K | 0.00% |
| Balyasny Asset Management LLC | 14,690 | $17.6K | 0.00% |
| Neuberger Berman Group LLC | 12,446 | $14.9K | 0.00% |
| Northwestern Mutual Wealth Management Co | 200 | $240 | 0.00% |
| Toronto Dominion Bank | 112 | $0 | 0.00% |
Sold out (25)
Institutions that held Gossamer Bio, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.